Aktionsplan National Research Corporation
Erweiterter Zeitplan
Einfaches Diagramm
Über das Unternehmen National Research Corporation
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. weitere detailsIPO date | 1997-10-10 |
---|---|
ISIN | US6373722023 |
Industry | Health Care Providers & Services |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Див.доход ао | 2.72 |
Дивиденд ао | 0.48 |
Сайт | https://www.nrchealth.com |
Цена ао | 14.59 |
Preisänderung pro Tag: | +1.64% (14.59) |
---|---|
Preisänderung pro Woche: | -1.85% (15.11) |
Preisänderung pro Monat: | -14.03% (17.25) |
Preisänderung über 3 Monate: | -16.64% (17.79) |
Preisänderung über sechs Monate: | -33.17% (22.19) |
Preisänderung pro Jahr: | -62.38% (39.42) |
Preisänderung über 3 Jahre: | -60.76% (37.79) |
Preisänderung über 5 Jahre: | -78.48% (68.92) |
Preisänderung über 10 Jahre: | 0% (14.83) |
Preisänderung seit Jahresbeginn: | -16.87% (17.84) |
|
Unterschätzung
|
Effizienz
|
|||||||||||||||||||||||||||||||||||||
Dividenden
|
Pflicht
|
Wachstumsimpuls
|
Dividende, % | Dividende | Basierend auf den Ergebnissen des Zeitraums | Vorher kaufen | Anmeldeschlussdatum | Auszahlung vorher |
---|---|---|---|---|---|
3.26% | 0.476 | III кв. 2024 | 25.12.2024 | 27.12.2024 | 13.01.2025 |
0.39% | 0.12 | II кв. 2024 | 25.09.2024 | 27.09.2024 | 14.10.2024 |
0.3% | 0.12 | IV кв. 2023 | 25.03.2024 | 27.03.2024 | 11.04.2024 |
0.29% | 0.12 | III кв. 2023 | 26.12.2023 | 28.12.2023 | 12.01.2024 |
Institutionen | Volumen | Aktie, % |
---|---|---|
Kayne Anderson Rudnick Investment Management LLC | 2881464 | 12.08 |
Blackrock Inc. | 1065585 | 4.47 |
Morgan Stanley | 943710 | 3.96 |
Vanguard Group Inc | 934644 | 3.92 |
Conestoga Capital Advisors, LLC | 780806 | 3.27 |
Dimensional Fund Advisors LP | 636402 | 2.67 |
QV Investors Inc. | 395102 | 1.66 |
Renaissance Technologies, LLC | 373584 | 1.57 |
Geode Capital Management, LLC | 356305 | 1.49 |
State Street Corporation | 342475 | 1.44 |
ETF | Aktie, % | Rentabilität für das Jahr, % | Dividenden, % |
---|---|---|---|
iShares MSCI USA Small-Cap Min Vol Factor ETF | 0.06502 | 18.2 | 1.66828 |
![]() |
0.02498 | 38.04 | 0.6026 |
iShares Morningstar Small-Cap Growth ETF | 0.01365 | 33.63 | 0.72598 |
iShares Morningstar Small-Cap Growth ETF | 0.01365 | 587.89 | 0.72598 |
iShares Morningstar Small-Cap ETF | 0.00669 | 30.1 | 1.60498 |
iShares Morningstar Small-Cap ETF | 0.00669 | 391.25 | 1.60498 |
iShares Russell 3000 ETF | 0.00055 | 24.83 | 1.43482 |
SPDR Portfolio Europe ETF | 0.00011 | 8.94 | 3.66537 |
Dimensional International Core Equity 2 ETF | 0.00006 | 6.52 | 3.69996 |
Aufsicht | Berufsbezeichnung | Zahlung | Geburtsjahr |
---|---|---|---|
Mr. Michael D. Hays | Founder, CEO, President & Director | 131.11k | 1955 (70 Jahre) |
Ms. Helen L. Hrdy | Chief Customer Officer | 291.51k | 1965 (60 Jahre) |
Mr. Jon Boumstein | Chief Delivery Officer | N/A | |
Megan Charko | Senior Manager of Content Marketing | N/A | |
Mr. Christophe Louvion | Chief Product & Technology Officer | N/A | 1973 (52 Jahr) |
Mr. Andy Monnich | Chief Corporate Development Officer | N/A | 1976 (49 Jahre) |
Mr. Jason Hahn | Chief Revenue Officer | N/A | 1972 (53 Jahr) |
Ms. Linda Stacy | Secretary | N/A | |
Ms. Vinitha Ramnathan | Chief Product Officer |
Adresse: United States, Lincoln. NE, 1245 Q Street - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://www.nrchealth.com
Webseite: https://www.nrchealth.com